Leptin could also drive the tumor to escape from immune attacks by enhancing fatty acid oxidation and tumor resistance to NK cell lysis via PGC-1 activation, thus showing a therapeutic clue for BC by blocking leptin (37). Here, LEP is linked to breast cancer.